极速pk10

诺孚泰简介

ABOUT US

诺孚泰简介

ABOUT US

广州诺孚泰医药科技有限公司作为安信医药的一员,时刻关注医药行业的最新需求,着手致力于扩展海外市场,与全球超过40家制药公司合作,借助他们对申报欧美NDA、IND及ANDA丰富的经验以及先进的技术,为国内客户提供美国,欧洲,日本上市许可的中国授权及先进制剂技术转移的高品质平台,为国内企业提供积极有效的帮助以及专业、可靠、全面的产品服务。

诺孚泰2016年成立以来,与来自欧洲、美国、加拿大、澳大利亚以及印度的大型临床研究中心合作,为客户提供临床研究服务并取得巨大成功。我们提供的临床研究服务类型多样、且合作模式灵活,可根据客户要求进行客制化方案定制服务;与我们建立有长期合作关系的临床研究中心均多次通过FDA及EMA审计,并有丰富的正式BE及预BE、新药临床试验经验。

除了国际资源,目前诺孚泰在国内也正根据美国FDA、EMA以及CFDA的要求,筹建属于自己的临床研究中心及生物检测中心,将于2019年下半年投入使用,为客户提供更加全方位的服务。

公司的发展离不开国内外客户与供应商的支持与帮助,我们愿与您精诚合作,同创共赢!

As part of Greensyn, Guangzhou Greensyn Lifescience Co., Ltd. has an insight into the latest demand of the pharmaceutical industry and is committed to expanding overseas markets. The cooperation with more than 40 global pharmaceutical companies is advancing, from whose extensive application experience in NDA, IND, ANDA and advanced technology we employ to provide the professional and comprehensive service of introducing the high quality pharmaceutical technology, accessing the marketing authorization in the western countries for domestic clients.

Greensyn has been accelerating the comprehensive cooperation with competitive CROs from Europe, USA, Canada, Australia and India since 2016 to provide the clinical research service for our clients, which achieves great success. Our clinical research service is various and the cooperation mode is flexible, which could be customized for our clients. All the CROs which has already established a long-term cooperation with us, have strong experience in conducting BE studies as well as clinical trails for FDA and EMA market.

极速pk10Besides, our own CRO and bio-analytical labs are under construction as per the standard of FDA, EMA and CFDA, it will start operating in second half of 2019.

极速pk10It will be a win-win situation if we join hand together, supports mutually, and build up our cooperation. 




极速pk10_安全购彩 极速pk10---极速pk10_欢迎您 极速pk10|官方唯一指定! 极速pk10_官网 极速pk10_官网 极速pk10---极速pk10_欢迎您 极速pk10_安全购彩 极速pk10-极速pk10 极速pk10|官方唯一指定! 极速pk10-极速pk10